Piracetam and other structurally related nootropics

@article{Gouliaev1994PiracetamAO,
  title={Piracetam and other structurally related nootropics},
  author={A. Gouliaev and A. Senning},
  journal={Brain Research Reviews},
  year={1994},
  volume={19},
  pages={180-222}
}
Nearly three decades have now passed since the discovery of the piracetam-like nootropics, compounds which exhibit cognition-enhancing properties, but for which no commonly accepted mechanism of action has been established. [...] Key Result No affinity for the alpha 1-, alpha 2-, beta-, muscarinic, 5-hydroxytryptamine-, dopamine, adenosine-A1-, mu-opiate, gamma-aminobutyric acid (GABA) (except for nefiracetam (GABAA)), benzodiazepine and glutamate receptors has been found. The racetams possess a very low…Expand

Paper Mentions

Nootropic Nefiracetam Inhibits Proconvulsant Action of Peripheral‐Type Benzodiazepines in Epileptic Mutant EL Mice
TLDR
Nefiracetam may prevent toxic effects of PBR agonists through interacting with PBR, a specific agonist for peripheral‐type benzodiazepine receptors (PBR) in EL mice. Expand
Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors
TLDR
The results suggest that nefiracetam may exert an anticonvulsant action through interacting with a low-affinity type of PBR in the brain, and could be developed as a promising therapeutic drug for neurological disorders including epilepsies. Expand
Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action
TLDR
Nefiracetam appears to facilitate hippocampal neurotransmission by functionally targeting nicotinic ACh receptors, independently of the action of piracetam and aniracetAM. Expand
Stereochemistry of phenylpiracetam and its methyl derivative: improvement of the pharmacological profile
Since the discovery of piracetam its structural analogs based on the pyrrolidin-2-one pharmacophore have aroused great interest as a source of effective pharmacological central nervous systemExpand
Piracetam and aniracetam antagonism of centrally active drug-induced antinociception
TLDR
The present results indicate that piracetam and aniracetam, by preventing both of the investigated effects of baclofen, have some selectivity against GABAB-mediated inhibition. Expand
An investigation of the neuropharmacological and behavioural effects of fenamate and other NSAIDs.
Recent evidence has indicated that NSAIDs might have direct effects on CNS tissue in addition to their classical inhibitory action on COX enzymes. This thesis addresses this hypothesis usingExpand
Pharmacological Characterization of the Novel ACh Releaser α‐tropanyl 2‐(4‐bromophenyl)propionate (PG‐9)
Ghelardini et al. (27) reported that atropine at very low doses induces central antinociception in rodents through an enhancement of cholinergic transmission. Soon after, it was discovered that theExpand
Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D‐glucose transport
TLDR
It is shown that piracetam and TRH antagonise the inhibition of glucose transport by barbiturates, diazepam, melatonin and endogenous neuropeptide galanin in human erythrocytes in vitro, showing similarities between amino‐acid sequences in human glucose transport protein isoform 1 (GLUT1) and the benzodiazepine‐binding domains of GABAA (gamma amino butyric acid) receptor subunits. Expand
Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats
TLDR
The results suggest that anticonvulsant spectrum and mechanism of nefiracetam are distinct from those of standard antiepileptic drugs, and nefIRacetam possesses a neuroprotective effect that is unrelated to seizure inhibition. Expand
Nonopioid and Neuropathy-Specific Analgesic Action of the Nootropic Drug Nefiracetam in Mice
TLDR
It is demonstrated that nefiracetam-induced analgesic action was nonopioid in nature and was due to stimulation of nicotinic cholinergic system at spinal and supraspinal levels and could be a good therapeutic tool against neuropathic pain. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 504 REFERENCES
Nootropic drugs and brain cholinergic mechanisms
  • G. Pepeu, G. Spignoli
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1989
TLDR
The information available is not yet sufficient to define at which steps of the cognitive process the action on cholinergic system plays a role and which are the influences of the changes in Cholinergic function on other neurochemical mechanisms of learning and memory. Expand
Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites.
TLDR
It is concluded that effects within the glutaminergic system of the brain could contribute to the therapeutical effects of piracetam in man. Expand
Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.
Piracetam is the first of the so-called 'nootropic' drugs, a unique class of drugs which affect mental function. In animal models and in healthy volunteers, the drug improves the efficiency of theExpand
Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy
TLDR
In this model, carbamazepine can reduce the severity of the epilepsy and at the same time reduce any memory deficit resulting from the epilepsy, while phenytoin is not a particularly effective anticonvulsant. Expand
Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
TLDR
Time- efficacy and dose-efficacy relationships in various EEG parameters give valuable information about the pharmacodynamics of such substances in man already at an early stage of drug development. Expand
New Pharmacological Perspectives on Nootropic Drugs
TLDR
While complete agreement between pharmacologists has not yet been attained, the vast majority agree that nootropic drugs have at least the following properties in common: they improve some aspect of cognitive performance—usually learning and/or memory in animals. Expand
Synthesis and anticonvulsant activity of 1-acyl-2-pyrrolidinone derivatives.
TLDR
The results suggested that the pharmacological activity of 1-acyl-2-pyrrolidinone is probably due to the release of GABA by hydrolysis of derivatives although further work is necessary. Expand
Investigations on the binding properties of the nootropic agent pyroglutamic acid.
The two stereoisomers of pyroglutamic acid (PCA), a nootropic or cognition-enhancing agent, and classic reference compounds were investigated for their ability to interact with 27 neurotransmitterExpand
Some neurochemical properties of pramiracetam (CI‐879), a new cognition‐enhancing agent
The present study was initiated to examine the effect of pramiracetam sulfate [N‐[2‐[bis(1‐methylethyl)amino]ethyl]‐2 oxo‐1‐pyrrolidineacetamide sulfate (1:1)] (PR), a new cognition‐activator agent,Expand
[Biochemical studies of oxiracetam (CT-848) on cholinergic neurons].
TLDR
The results suggest that oxiracetam enhances precholinergic functions, and does not affect the acetylcholinesterase activity in mouse brain homogenate. Expand
...
1
2
3
4
5
...